PMH61 PATIENTS PREFERENCES IN ADULTS WITH ADHD—A DISCRETE CHOICE EXPERIMENT
نویسندگان
چکیده
منابع مشابه
Eliciting Preferences for Health Insurance in Iran Using Discrete Choice Experiment Analysis
Background The preferences of Iranians concerning the attributes of health insurance benefit packages are not well studied. This study aimed to elicit health insurance preferences among insured people in Iran during 2016. Methods A mixed method...
متن کاملEvaluation of Preferences in Receiving Facilities Using Discrete Choice Experiment Technique
The present study evaluates the effect of some of the most important variables affecting the preferences of bank loan applicants, based on the discrete choice test method. Initially, the variables and their levels were identified after consultation with banking experts and the required information was collected through a questionnaire. The results show that any increase in interest rates, inten...
متن کاملPatients' preferences in anticoagulant therapy: discrete choice experiment.
BACKGROUND With proliferating treatment options for anticoagulant therapy, physicians and patients must choose among them based on their benefits and risks. Using a Discrete Choice Experiment, we elicited patients' relative preferences for specific benefits and risks of anticoagulant therapy. METHODS AND RESULTS We selected a sample of US patients with cardiovascular disease from an online pa...
متن کاملPatients’ preferences for osteoporosis drug treatment: a discrete-choice experiment
INTRODUCTION The patient's perspective is becoming increasingly important in clinical and policy decisions. In this study, we aimed to evaluate the preferences of patients with, or at risk of, osteoporosis for medication attributes, and to establish how patients trade between these attributes. METHODS A discrete choice experiment survey was designed and patients were asked to choose between t...
متن کاملThe First Discrete Choice Experiment On Usage of Bypassing Agents in Hemophilic Patients in Iran
Background: Bleeding events in hemophilic patients with inhibitors are managed by bypassing agents. Currently available agents in Iran are recombinant activated factor VII (rfVIIa; Aryogen, Aryoseven) and Feiba (factor eight inhibitor bypassing agent). No standardized and accurate assay is currently available for monitoring the effectiveness of bypassing agents. We suggested that history of the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2009
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)74780-x